04:03 PM EDT, 05/05/2025 (MT Newswires) -- Health care stocks fell late Monday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.4%.

The iShares Biotechnology ETF (IBB) shed 0.6%.

In corporate news, Integra LifeSciences ( IART ) shares tumbled past 21%. Adjusted earnings in Q1 trailed Wall Street estimates, and the company cut 2025 adjusted EPS guidance.

Immutep ( IMMP ) shares surged 46% after it said Monday that a phase 2b trial evaluating eftilagimod alfa in combination with Merck's (MRK) Keytruda as first line therapy in head and neck cancer patients produced an "excellent" median overall survival result of 17.6 months.

BioNTech (BNTX) shares dropped 3.6% after the company reported an unexpected decline in Q1 sales.

Capricor Therapeutics ( CAPR ) shares fell 13% after the company said the US Food and Drug Administration plans to hold an advisory committee meeting to review its biologics license application for deramiocel, an investigational cell therapy for treating cardiomyopathy in Duchenne muscular dystrophy patients.